Filing Details
- Accession Number:
- 0001493152-23-032794
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-15 17:15:30
- Reporting Period:
- 2023-09-14
- Accepted Time:
- 2023-09-15 17:15:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1357459 | Palisade Bio Inc. | PALI | Biological Products, (No Disgnostic Substances) (2836) | 522007292 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1849917 | J. Robert Trenschel | 7750 El Camino Real, Suite 2A Carlsbad, CA 92009 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.01 | Disposition | 2023-09-14 | 300 | $0.64 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Reflects the weighted average sale price. The range of prices for such transaction was $0.6396 to $0.6507. Open market sale transactions were made on the same day at different prices through a trade order executed by a broker-dealer. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.